Gregory S. Weishar is CEO at PharMerica CORP (PMC). They have made 10 open-market trades across 1 company since 2007, most recently 2017-12-07.
CIK 0001194422
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
6 open-market purchases totalling $1.9M since 2007, against 4 sales. Across 6 scored buys the stock is down 4.5% at ninety days, and 4.8 points behind the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 0% | 0% |
| Avg Move | -11.5% | -4.5% | -4.5% |
| Alpha | -5.6% | -4.8% | -4.8% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PMC | SELL | 2017-12-07 | 2017-12-11 | $29.25 | $30.4M | N/A | N/A | N/A |
| PMC | SELL | 2015-06-02 | 2015-06-08 | $32.97 | $754K | -11.5% | -4.5% | -4.5% |
| PMC | SELL | 2015-06-02 | 2015-06-04 | $32.63 | $3.4M | -11.5% | -4.5% | -4.5% |
| PMC | SELL | 2014-03-14 | 2014-03-17 | $26.27 | $1.6M | -11.5% | -4.5% | -4.5% |
| PMC | BUY | 2012-06-14 | 2012-06-15 | $9.47 | $336K | -11.5% | -4.5% | -4.5% |
| PMC | BUY | 2012-02-29 | 2012-03-01 | $12.30 | $246K | -11.5% | -4.5% | -4.5% |
| PMC | BUY | 2010-08-13 | 2010-08-13 | $7.68 | $622K | -11.5% | -4.5% | -4.5% |
| PMC | BUY | 2010-05-24 | 2010-05-25 | $16.00 | $160K | -11.5% | -4.5% | -4.5% |
| PMC | BUY | 2009-11-12 | 2009-11-16 | $14.87 | $372K | -11.5% | -4.5% | -4.5% |
| PMC | BUY | 2007-12-14 | 2007-12-18 | $14.00 | $140K | -11.5% | -4.5% | -4.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.